• 617-632-3012
  • This email address is being protected from spambots. You need JavaScript enabled to view it.


Center for Cancer Computational Biology (CCCB)

The mission of the Center for Cancer Computational Biology (CCCB) is to further the Dana-Farber Cancer Institute's commitment to advance the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. We aim to do that by providing broad-based support for the analysis and interpretation of 'omic data and in doing so, further basic, clinical, and translational research and to conduct research that opens new ways of understanding human cancer. 

The cBio Center at Dana-Farber

The cBio Center at Dana-Farber's mission is to provide oncologists with tools to mine genomic patient data for research and for guiding treatment decisions, devise strategies to overcome resistance to targeted cancer drugs and create new connections between scientists at Dana-Farber and Harvard Medical School, including collaborative structures for scientists using quantitative sciences to solve biological problems.

Center for Functional Cancer Epigenetics (CFCE)

The mission for Center for Functional Cancer Epigenetics (CFCE) is to explore the key role that epigenetic alterations and abnormal transcriptional regulation play in the development and progression of cancer. A better understanding of these alterations will lead to better diagnosis for cancer and the potential to contribute to the knowledge required for the development of new therapeutics exploiting epigenetic mechanisms.

ECOG-ACRIN Cancer Research Group

The department is the statistical center for ECOG-ACRIN, which designs and conducts biomarker-driven cancer research involving adults who have cancer or are at risk. We have boldly integrated therapeutic and diagnostic imaging-based research disciplines with the latest bioinformatics technologies into a single scientific organization. 

Dana-Farber/Harvard Cancer Center (DF/HCC)

The DF/HCC is a designated NCI Comprehensive Cancer Center comprised of seven Boston institutions. The cancer research and treatment collaborations sponsored across participating institutions by the DF/HCC combine the disciplines of population science, clinical science, and basic research to facilitate the development of novel and improved modalities for the prevention and treatment of cancer.

Center for Cancer Evolution (CCE)

The Center for Cancer Evolution (CCE) was founded in 2016 and focuses on understanding cancer evolution through a multi-disciplinary approach. Our goal is to understand the mechanisms behind tumor evolution, metastasis formation, emergence of drug resistance to ultimately provide more specialized and effective patient care in a variety of different cancer types.

International Breast Cancer Study Group (IBCSG)

The IBCSG is a non-profit research organization dedicated to innovative clinical research to improve the prognosis of women with breast cancer. Patients and investigators from over 500 sites on 6 continents (Europe, Australia/New Zealand, Africa, Asia, North and South America) cooperate by participating in extensive clinical trials in breast cancer populations, guided by the highest scientific and ethical standards.


© 2018 All Rights Reserved.